Table 1.
Generalized Estimating Equations Logistic Model of Craving Predicting Alcohol Use Over the Next 1 Week (N=1350)
| B | SEB | OR | Lower 95% CI | Upper 95% CI | p | |
|---|---|---|---|---|---|---|
| Age | 0.004 | 0.004 | 1.00 | 1.00 | 1.01 | 0.29 |
| Gender (reference = male) | −0.28 | 0.09 | 0.76 | 0.63 | 0.90 | 0.01 |
| Treatment (reference = Pill placebo) | ||||||
| Acamprosate | 0.62 | 0.32 | 1.86 | 0.99 | 3.48 | 0.05 |
| Naltrexone | 0.28 | 0.31 | 1.32 | 0.72 | 2.43 | 0.37 |
| Acamprosate+naltrexone | 0.16 | 0.32 | 1.17 | 0.63 | 2.20 | 0.63 |
| Pill placebo+CBT | 0.32 | 0.33 | 1.38 | 0.72 | 2.63 | 0.33 |
| Acamprosate+CBT | 0.58 | 0.30 | 1.79 | 0.99 | 3.22 | 0.05 |
| Naltrexone+CBT | 0.32 | 0.30 | 1.38 | 0.76 | 2.48 | 0.29 |
| Acamprosate+naltrexone+CBT | 0.14 | 0.32 | 1.15 | 0.61 | 2.15 | 0.66 |
| CBT | 0.58 | 0.31 | 1.79 | 0.97 | 3.28 | 0.06 |
| Site (reference =1) | ||||||
| 2 | −0.01 | 0.18 | 0.99 | 0.69 | 1.40 | 0.93 |
| 3 | 0.01 | 0.16 | 1.01 | 0.73 | 1.39 | 0.94 |
| 4 | −0.41 | 0.18 | 0.67 | 0.47 | 0.95 | 0.02 |
| 5 | −0.75 | 0.20 | 0.47 | 0.32 | 0.69 | 0.00 |
| 6 | −0.42 | 0.18 | 0.66 | 0.46 | 0.94 | 0.02 |
| 7 | −0.84 | 0.19 | 0.43 | 0.30 | 0.63 | 0.00 |
| 8 | −0.17 | 0.18 | 0.85 | 0.59 | 1.21 | 0.36 |
| 9 | −0.04 | 0.17 | 0.96 | 0.69 | 1.35 | 0.82 |
| 10 | −0.41 | 0.17 | 0.67 | 0.48 | 0.93 | 0.02 |
| 11 | −0.38 | 0.16 | 0.68 | 0.49 | 0.94 | 0.02 |
| Alcohol use previous week | 2.93 | 0.16 | 18.73 | 13.69 | 25.63 | <.001 |
| Time | −0.06 | 0.03 | 0.94 | 0.89 | 1.00 | 0.05 |
| Craving Scale | 0.27 | 0.06 | 1.31 | 1.16 | 1.47 | <.001 |
| Craving Scale X Time | 0.03 | 0.01 | 1.03 | 1.01 | 1.05 | 0.03 |
| Craving Scale X Alcohol use previous week | −0.07 | 0.03 | 0.93 | 0.88 | 0.99 | 0.04 |
Note. Non-significant interaction terms for Craving Scale by Treatment (Wald Chi-Square=9.40, p=.31) and Craving Scale by Treatment by Time (Wald Chi-Square=9.40, p=.31) are not presented in the table. OR=odds ratio; CI=Confidence Interval; CBT=cognitive behavioral therapy.